Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
28/08/2025
Japanese two-year government bond auction faced the weakest demand ratio since 2009.
Latest
2 m ago
According to AI Fast News, Pacific Securities issued a research report on August 28, giving a recommendation to increase holdings of Baicheng Pharmaceuticals (301096.SZ). The main reasons for the recommendation include: 1) Revenue is lower than expected, and profits are under pressure; 2) The year-on-year decline in revenue of various businesses, while the profitability of clinical business is improving; 3) Continuously strengthening the research and development team, optimizing the research and development project structure. (Daily Economic News)
2 m ago
Yatai Group is planning to sell its stake in Northeast Securities, and the transaction is still in progress.
3 m ago
Changlian Co., Ltd. (603648.SH) released its semi-annual results, with a net profit attributable to the parent company of 68.31 million yuan, a year-on-year decrease of 14.62%.
3 m ago
Fangzheng Technology: Net profit in the first half of the year was 173 million yuan, a year-on-year increase of 15.29%.
3 m ago
Baiyang Pharmaceutical (301015.SZ) released its performance for the first half of the year, with a net profit attributable to the parent company of 163 million yuan, a decrease of 59.48%.
See all latest